Edition:
United States

Vascular Biogenics Ltd (VBLT.OQ)

VBLT.OQ on NASDAQ Stock Exchange Global Market

6.95USD
3:59pm EST
Change (% chg)

$0.35 (+5.30%)
Prev Close
$6.60
Open
$6.55
Day's High
$6.95
Day's Low
$6.45
Volume
41,230
Avg. Vol
53,658
52-wk High
$9.05
52-wk Low
$3.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.241
Jun '17 0.00 -0.180
Mar '17 0.00 -0.187
FY 2016 Dec '16 0.00 -0.179
Sep '16 0.00 -0.119
Jun '16 0.00 -0.139
Mar '16 0.00 -0.210
FY 2015 Dec '15 0.00 -0.147
Sep '15 0.00 -0.290
Jun '15 0.00 -0.149
Mar '15 0.00 -0.150
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 5.00 15.00 0.00 0.00
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 3 5.00 15.00 0.00 0.00
Year Ending Dec-18 3 4.53 13.60 0.00 3.40
Earnings (per share)
Quarter Ending Dec-17 3 -0.05 0.34 -0.27 -0.17
Quarter Ending Mar-18 2 -0.22 -0.21 -0.22 --
Year Ending Dec-17 2 -0.55 -0.27 -0.83 -0.66
Year Ending Dec-18 4 -0.83 -0.50 -1.02 -0.65
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.97 35.27
P/E High - Last 5 Yrs. -- 274.53 45.26
P/E Low - Last 5 Yrs. -- 92.51 24.18
Beta -- 0.83 0.91
Price to Sales (TTM) -- 114.29 5.83
Price to Book (MRQ) 5.87 22.17 5.62
Price to Tangible Book (MRQ) 6.48 25.97 7.22
Price to Cash Flow (TTM) -- 101.40 24.19
% Owned Institutions 26.54 5.64 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.04
Dividend 5 Year Growth Rate -- 1.96 5.26
Payout Ratio(TTM) -- 96.00 46.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -3.18 6.84
Sales (TTM) vs TTM 1 Yr. Ago -- 30.07 5.66
Sales - 5 Yr. Growth Rate -- 33.24 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -103.07 -149.23 7.22
EPS (TTM) vs TTM 1 Yr. Ago -28.04 -- --
EPS - 5 Yr. Growth Rate -- 43.30 10.92
Capital Spending - 5 Yr. Growth Rate -- 40.86 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 5.86 5.74 3.56
LT Debt to Equity (MRQ) 0.00 14.43 13.40
Total Debt to Equity (MRQ) 0.00 16.88 19.46
Interest Coverage (TTM) -- -147.14 44.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.80 54.92
Gross Margin - 5 Yr. Avg. -- 55.48 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -218.62 15.49
Operating Margin (TTM) -- -632.11 6.65
Operating Margin - 5 Yr. Avg. -- -235.48 10.97
Pre-Tax Margin (TTM) -- -603.10 7.47
Pre-Tax Margin - 5 Yr. Avg. -- -235.80 11.38
Net Profit Margin (TTM) -- -600.62 3.70
Net Profit Margin - 5 Yr. Avg. -- -239.05 7.67
Effective Tax Rate (TTM) -- 15.26 24.26
Effective Tax Rate - 5 Yr. Avg. -- 18.70 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,614,065 848,695,288
Net Income/Employee (TTM) -- -1,754,114 99,009,570
Receivable Turnover (TTM) -- 25.64 6.11
Inventory Turnover (TTM) -- 2.61 3.55
Asset Turnover (TTM) 0.00 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -49.64 -9.38 11.28
Return on Assets - 5 Yr. Avg. -- 0.11 12.25
Return on Investment (TTM) -55.33 -11.84 14.40
Return on Investment - 5 Yr. Avg. -- 3.18 16.04
Return on Equity (TTM) -55.45 -36.93 15.99
Return on Equity - 5 Yr. Avg. -- 5.57 17.25
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Vascular Biogenics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.54%
# of Holders: 28
Total Shares Held: 7,889,019
3 Mo. Net Change: -1,074,086
# New Positions: 4
# Closed Positions: 6
# Increased Positions: 9
# Reduced Positions: 13
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.